LeMaitre to Participate at Upcoming Investor Conferences in December
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) has announced its participation in two major investor conferences this December. David Roberts, President, will present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024, at 3:30 PM EST in New York City. Additionally, he will present at the Stifel "MedTech Madness" West Coast Bus Tour on December 12, 2024, at 11:45 AM PST in Menlo Park, California.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
In the trading session that priced this news, LMAT declined 1.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December.
David Roberts, President, will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at the Lotte New York Palace in New York City. The company’s presentation is scheduled for 3:30 PM EST.
He is also scheduled to present at the Stifel “MedTech Madness” West Coast Bus Tour at the Rosewood Sand Hill in Menlo Park, CA on Thursday, December 12, 2024, at 11:45 AM PST.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact:
Gregory Manker
Director, Business Development & Investor Relations
LeMaitre Vascular, Inc.
+1-781-362-1260
gmanker@lemaitre.com
